Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/ILA stock hub

ASX/ILA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/ILAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

104.3M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/ILA

In the news

Latest news · ASX/ILA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROE-130.3

P25 -118.7P50 -49.4P75 -1.2

ROIC-83.3

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/ILA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

148

Groups with data

Currency

AUD

Showing 148 of 148 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Enterprise value	AUD 97.4M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Isin	AU0000138869
Last refreshed	2026-05-10
Market cap	AUD 104.3M
Price	AUD 0.35
Price currency	AUD
Sector	Healthcare
Sic	2834
Symbol	asx/ILA
Website	https://www.islandpharmaceuticals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.9%
EV Earnings	-13.54x
P/B ratio	14.57x
P/S ratio	1,659.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	AUD -2M
Net Income	AUD -7.2M
Net Income Growth Years	0%
Pretax Margin	-11,452.57%
ROA	-74.67
Roa5y	-49.96
ROCE	-102.9
ROE	-130.3
Roe5y	-94.32
ROIC	-83.32

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	113.44%
Cagr3y	67.94%
Cagr5y	-0.57%
EPS Growth Years	2
Revenue Growth	-84.26x
Revenue Growth Q	-57.89x
Revenue Growth Years	0x
Revenue Growth3 Y	-63.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.01
Assets	AUD 8M
Cash	AUD 6.9M
Current Assets	AUD 7.2M
Current Liabilities	AUD 860,154
Equity	AUD 7.2M
Liabilities	AUD 860,154
Long Term Assets	AUD 789,058
Long Term Liabilities	AUD 0
Net Cash	AUD 6.9M
Net Cash By Market Cap	AUD 6.59
Net Cash Growth	72.07%
Net Debt Equity	AUD -0.96
Tangible Book Value	AUD 6.4M
Tangible Book Value Per Share	AUD 0.02
WACC	4.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.4
Net Working Capital	AUD -501,545
Quick ratio	8.21
Working Capital	AUD 6.4M
Working Capital Turnover	AUD 0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-88.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	113.33%
200-day SMA	0.37
3Y total return	373.85%
50-day SMA	0.38
50-day SMA vs 200-day SMA	50over200
5Y total return	-2.8%
All Time High	0.67
All Time High Change	-47.46%
All Time High Date	2021-04-13
All Time Low	0.05
All Time Low Change	604%
All Time Low Date	2024-04-22
ATR	0.02
Beta	0.12
Beta1y	-1.43
Beta2y	-1.35
Ch YTD	-18.14
High	0.35
High52	0.63
High52 Date	2025-11-24
High52ch	-44.13%
Low	0.35
Low52	0.13
Low52 Date	2025-07-01
Low52ch	170.77%
Ma50ch	-8.19%
Price vs 200-day SMA	-5.83%
RSI	40.03
RSI Monthly	57.77
RSI Weekly	45.72
Sharpe ratio	1.29x
Sortino ratio	2.37
Total Return	-88.25%
Tr YTD	-18.14
Tr1m	-3.56%
Tr1w	-4.86%
Tr3m	-16.19%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -7.4M
Operating margin	-11,715.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	150,437,940%
Shares Insiders	40.34%
Shares Institutions	4.6%
Shares Out	295,916,682
Shares Qo Q	24.5%
Shares Yo Y	88.25%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	154,613.95x
Bv Per Share	0.03
Ch1m	-3.56
Ch1w	-4.86
Ch1y	113.3
Ch3m	-16.19
Ch3y	340
Ch5y	-9.74
Ch6m	-15.18
Change	0.57%
Change From Open	0.57
Close	0.35
Days Gap	0
Depreciation Amortization	52,645
Dollar Volume	17,917.9
Earnings Date	2026-05-26
EBIT	AUD -7.4M
EPS	AUD -0.03
F Score	1
Financing CF	7,405,027
Fiscal Year End	June
Founded	2,017
Investing CF	-841,703
Is Primary Listing	1
Last Earnings Date	2026-02-22
Last Report Date	2025-12-31
Ma150	0.42
Ma150ch	-16.09%
Ma20	0.37
Ma20ch	-4.19%
Net CF	2,877,291
Next Earnings Date	2026-05-26
Open	0.35
Position In Range	100
Price Date	2026-05-08
Ptbv Ratio	16.38
Relative Volume	0.33x
Revenue	62,851x
SBC By Revenue	1,195.76x
Share Based Comp	751,547
Tr6m	-15.18%
Volume	50,903
Z Score	35.76

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/ILA pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/ILA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/ILA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.6%

Share of float held by funds and institutions

Insider ownership

+40.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+88.3%

Negative means the company is buying back shares.

Technical

ASX/ILA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.0

Neutral momentum band

Price vs 200-day MA

-5.8%

50/200-day relationship not available

Beta (5Y)

0.12

Less volatile than the market

Sharpe ratio

1.29

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/ILA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/ILA stock rating?

asx/ILA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/ILA analysis?

The full report lives at /stocks/asx/ILA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/ILA?

The latest report frames asx/ILA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/ILA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.